X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (60786) 60786
Book Chapter (88) 88
Magazine Article (64) 64
Publication (35) 35
Conference Proceeding (13) 13
Book Review (10) 10
Dissertation (9) 9
Book / eBook (3) 3
Government Document (1) 1
Newsletter (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48878) 48878
multicenter (34139) 34139
female (27840) 27840
male (25412) 25412
middle aged (21157) 21157
aged (17226) 17226
adult (17000) 17000
treatment outcome (14232) 14232
multicenter studies as topic (12762) 12762
oncology (10278) 10278
surgery (8713) 8713
randomized controlled trials as topic (8304) 8304
double-blind (7492) 7492
trial (6446) 6446
aged, 80 and over (6323) 6323
prospective studies (6300) 6300
care and treatment (6022) 6022
therapy (5712) 5712
retrospective studies (5640) 5640
risk factors (5567) 5567
cancer (5448) 5448
efficacy (5306) 5306
adolescent (5296) 5296
chemotherapy (5255) 5255
analysis (5210) 5210
clinical trials (5131) 5131
time factors (4939) 4939
medicine & public health (4800) 4800
follow-up studies (4792) 4792
research (4309) 4309
pharmacology & pharmacy (4287) 4287
clinical neurology (4252) 4252
medicine, general & internal (4234) 4234
cardiac & cardiovascular systems (4233) 4233
double-blind method (4121) 4121
prognosis (4102) 4102
mortality (4071) 4071
management (4013) 4013
clinical trials as topic (3820) 3820
patients (3802) 3802
safety (3628) 3628
health aspects (3626) 3626
gastroenterology & hepatology (3518) 3518
survival (3480) 3480
young adult (3474) 3474
abridged index medicus (3473) 3473
child (3249) 3249
antineoplastic combined chemotherapy protocols - therapeutic use (3190) 3190
multicenter trial (3126) 3126
drug therapy (2960) 2960
open-label (2822) 2822
hematology (2770) 2770
diagnosis (2701) 2701
quality of life (2679) 2679
outcomes (2674) 2674
medical research (2630) 2630
risk (2474) 2474
medicine, research & experimental (2290) 2290
studies (2278) 2278
survival analysis (2252) 2252
follow-up (2208) 2208
prevention (2206) 2206
severity of illness index (2195) 2195
recurrence (2148) 2148
animals (2146) 2146
usage (2144) 2144
drug therapy, combination (2130) 2130
children (2082) 2082
pediatrics (2082) 2082
medicine (2059) 2059
urology & nephrology (2041) 2041
drug administration schedule (2029) 2029
complications (2019) 2019
metaanalysis (2010) 2010
survival rate (2010) 2010
disease (2003) 2003
randomized-trial (1986) 1986
neoplasm staging (1969) 1969
psychiatry (1957) 1957
medicine, experimental (1941) 1941
cohort studies (1903) 1903
combined modality therapy (1862) 1862
child, preschool (1852) 1852
dose-response relationship, drug (1843) 1843
metastasis (1814) 1814
disease-free survival (1808) 1808
peripheral vascular disease (1787) 1787
united states (1776) 1776
antineoplastic agents - therapeutic use (1750) 1750
radiology, nuclear medicine & medical imaging (1745) 1745
internal medicine (1742) 1742
neurosciences (1739) 1739
placebo-controlled trial (1733) 1733
patient outcomes (1732) 1732
quality-of-life (1712) 1712
prevalence (1711) 1711
research design (1677) 1677
risk assessment (1668) 1668
immunology (1626) 1626
carcinoma (1598) 1598
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57570) 57570
German (1377) 1377
French (942) 942
Spanish (487) 487
Japanese (443) 443
Italian (168) 168
Russian (149) 149
Chinese (72) 72
Portuguese (51) 51
Polish (34) 34
Dutch (31) 31
Danish (26) 26
Hungarian (25) 25
Turkish (19) 19
Swedish (15) 15
Czech (12) 12
Lithuanian (10) 10
Korean (9) 9
Norwegian (7) 7
Hebrew (3) 3
Icelandic (3) 3
Serbian (3) 3
Bulgarian (1) 1
Catalan (1) 1
Croatian (1) 1
Finnish (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1986, Monographs in epidemiology and biostatistics, ISBN 0195035682, Volume 8, xxvi, 469 p. --
This book starts with a general discussion of clinical trials. It goes on to describe the activities of a typical study, comparing single center and multicenter... 
Clinical Trials | public health and epidemiology | Quality assurance | Execution | Sample size estimates | Costs factors | Multicenter trials | Single center trials | Typical study | Treatment masking | Design principles | Follow-up
Book
Stroke; a journal of cerebral circulation, ISSN 0039-2499, 2014, Volume 45, Issue 3, pp. 781 - 787
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10022, pp. 945 - 956
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 317 - 328
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10038, pp. 2630 - 2640
.... The efficacy and safety of tocilizumab, an interleukin 6 receptor-α inhibitor, was assessed in the faSScinate phase 2 trial in patients with systemic sclerosis... 
Internal Medicine | Medicine(all) | Multicenter Study | Clinical Trial, Phase II | Randomized Controlled Trial | Research Support, Non-U.S. Gov't | Journal Article | INTERSTITIAL LUNG-DISEASE | MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | PLACEBO | LYSOPHOSPHATIDIC ACID | DIFFUSE SCLERODERMA | SKIN FIBROSIS | INTERLEUKIN-6 | EXPRESSION | SSC SKIN | Biomarkers - metabolism | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Europe | Humans | Middle Aged | Scleroderma, Systemic - metabolism | Male | Treatment Outcome | United Kingdom | Canada | Vital Capacity | Antibodies, Monoclonal, Humanized - administration & dosage | Injections, Subcutaneous | Scleroderma, Systemic - complications | Interleukin-6 - physiology | Adult | Female | Aged | Scleroderma, Systemic - drug therapy | Medical colleges | Adults | Systemic scleroderma | Interleukins | Scleroderma (Disease) | Analysis | Tissue | Cytokines | Ulcers | Biomarkers | Fibroblasts | Clinical trials | Patient safety | Skin diseases | Skin | Health risk assessment | Scleroderma | Drug therapy | Pathogenesis | Interleukin | Evidence-based medicine | Itching | Interleukin 6 | Cost-benefit analysis | Safety | Thickening | Effectiveness | Mortality | Lung diseases | Medical treatment | Rheumatology | Patients | Studies | Systemic sclerosis | Least squares | Autoimmune diseases
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 2015, Volume 10, Issue 3, pp. 486 - 491
Journal Article